Skip to main content

ALF transcription elongation factor 2

The AFF2 gene provides instructions for making a protein that is found in the nucleus of cells but whose function is not well understood. Some studies suggest that it acts as a transcription factor, which means that it attaches (binds) to specific regions of DNA and helps control the activity of other genes, although the identity of these genes is unknown. Other studies show that the protein can attach to specific regions of messenger RNA (mRNA), which is a chemical cousin of DNA that serves as the genetic blueprint for protein production. It is thought that the AFF2 protein helps control the process by which the mRNA blueprint is cut and rearranged to produce different versions of proteins (alternative splicing).

Video picks for Genes
Video library

Normal function

The AFF2 gene provides instructions for making a protein that is found in the nucleus of cells but whose function is not well understood. Some studies suggest that it acts as a transcription factor, which means that it attaches (binds) to specific regions of DNA and helps control the activity of other genes, although the identity of these genes is unknown. Other studies show that the protein can attach to specific regions of messenger RNA (mRNA), which is a chemical cousin of DNA that serves as the genetic blueprint for protein production. It is thought that the AFF2 protein helps control the process by which the mRNA blueprint is cut and rearranged to produce different versions of proteins (alternative splicing).

One region of the AFF2 gene contains a particular DNA segment known as a CCG trinucleotide repeat, so called because this segment of three DNA building blocks (nucleotides) is repeated multiple times within the gene. In most people, the number of CCG repeats ranges from 6 to about 30.

Conditions referring to this gene or chromosome

Other names

AFF2_HUMAN

FMR2

FMR2P

FRAXE

MRX2

Patient picks for Genes

Related patient information and medicines

Liver failure

Patient information leaflet

Liver failure

How common is liver failure. Acute liver failure is very uncommon: In England , there were 688 liver transplants, 28 in Scotland, 69 in Wales and 24 in Northern Ireland performed in the year April 2021 to April 2022. The number of transplants increased by 11% from the previous year. The number of ... The outlook for acute liver failure (ALF) has.

Psoriatic arthritis

Patient information leaflet

Psoriatic arthritis

Some DMARDs also have a beneficial effect on r... Newer disease-modifying medicines A new class of recently developed medicines modify the effect of TNF alpha. The chemical TNF alpha plays an important role in causing inflammation in joints and skin. Blocking the effect of TNF alpha has been shown to reduce damage to joints and to reduce symptoms..

Retinal vein occlusion

Patient information leaflet

Retinal vein occlusion

Minimising the damaging effects T... A number of different treatments are used with the aim of reducing the swelling, so that the retina can recover. The earlier this is done, the better the chance of some recovery: Anti-vascular endothelial growth factor (anti-VEGF). These medicines, which include ranibizumab, bevacizumab and aflibercept, stop.

Blood clotting tests

Patient information leaflet

Blood clotting tests

Blood clotting tests are used to diagnose and assess bleeding problems and to monitor people who take warfarin or other anticoagulant medicines. You may be advised to have blood clotting tests: If you have a suspected bleeding disorder. For example, if you bleed a lot after cuts, or if you bruise easily. If you have certain liver diseases that can.

Transient ischaemic attack

Patient information leaflet

Transient ischaemic attack

If you have diabetes , treatment to keep your blood sugar as near normal as possible is important. See the separate leaflet called Cardiovascular disease (Atheroma) for more details Cardiovascular disease. Transient ischaemic attack (TIA) and driving If you've had, or currently have, a medical condition or disability that may affect your driving.

Haemophilia

Patient information leaflet

Haemophilia

Haemophilia is a rare bleeding disorder that affects your ability to make a clot. The blood contains substances called clotting factors that work with platelets to form a clot. When you injure yourself the clot stops you bleeding. Haemophilia is a condition where there is a deficiency of clotting factors, so people with this condition usually have.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 17 Jul 2024 | Latest version
  • 1 Jan 2014 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.